CSE: PHRMOTCQB: PHRRF
Contact us
Menu

Newsroom

Press releases and media contact.

Press releases

Get news alerts →
March 16, 2021
Pipeline
World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor
March 2, 2021
Platform & partnering
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig's Disease
March 1, 2021
Financial
Newscope Announces DTC Eligibility of Its Common Shares in the United States
February 23, 2021
Platform & partnering
PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic Pharmaceuticals
February 17, 2021
Pipeline
PharmaTher Announces Sale of Psilocybin Program
February 4, 2021
Pipeline
PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease
February 1, 2021
Platform & partnering
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine
January 19, 2021
Platform & partnering
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders
January 13, 2021
Financial
PharmaTher Approved to Trade on the OTCQB Venture Market
December 30, 2020
Financial
PharmaTher Announces Application for OTCQB Listing
December 21, 2020
Pipeline
PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics
December 15, 2020
Pipeline
PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders
December 10, 2020
Pipeline
PharmaTher Granted Pre-IND Meeting with the FDA for Ketamine in Parkinson’s Disease
December 8, 2020
Pipeline
PharmaTher Files FDA Pre-IND Meeting Request for Ketamine in Parkinson’s Disease
November 24, 2020
Pipeline
PharmaTher Provides Update on its Psychedelic Pharmaceuticals Programs
November 18, 2020
Platform & partnering
PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform
November 16, 2020
Pipeline
PharmaTher Expands Patent Portfolio with Filing of U.S. Patent for Novel Use of Psilocybin to Treat Cancer
November 11, 2020
Pipeline
Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor
October 29, 2020
Pipeline
Leading Parkinson’s Researcher Dr. Robert A. Hauser Joins Pharmather as Scientific Advisor
October 22, 2020
Pipeline
Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals

All PharmaTher press releases since October 2020, newest first.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.